UBS O'Connor’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-13,133
| Closed | -$120K | – | 570 |
|
|
2023
Q3 | $120K | Hold |
13,133
| – | – | ﹤0.01% | 424 |
|
|
2023
Q2 | $277K | Sell |
13,133
-937
| -7% | -$19.8K | 0.01% | 453 |
|
|
2023
Q1 | $379K | Buy |
+14,070
| New | +$379K | 0.01% | 468 |
|
|
2022
Q4 | – | Sell |
-7,401
| Closed | -$1.67M | – | 479 |
|
|
2022
Q3 | $1.67M | Sell |
7,401
-2,742
| -27% | -$619K | 0.02% | 664 |
|
|
2022
Q2 | $1.92M | Buy |
+10,143
| New | +$1.92M | 0.02% | 662 |
|
|
2019
Q4 | – | Sell |
-1,713
| Closed | -$527K | – | 310 |
|
|
2019
Q3 | $527K | Buy |
+1,713
| New | +$527K | 0.01% | 222 |
|
|
2014
Q4 | – | Sell |
-56
| Closed | -$262K | – | 697 |
|
|
2014
Q3 | $262K | Buy |
+56
| New | +$262K | ﹤0.01% | 388 |
|